3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
54
Biliary Tract Neoplasms
23
Nasopharyngeal Carcinoma
22
Carcinoma, Non-Small-Cell Lung
22
Cholangiocarcinoma
21
Urinary Bladder Neoplasms
18
Breast Neoplasms
18
Neoplasm Metastasis
17
Lung Neoplasms
14
Lymphoma, Large B-Cell, Diffuse
13
Colorectal Neoplasms
12
Carcinoma, Transitional Cell
12
Non-Muscle Invasive Bladder Neoplasms
10
Recurrence
8
Ovarian Neoplasms
8
Triple Negative Breast Neoplasms
7
Sarcoma
7
Neoplasms
6
Hodgkin Disease
6
Gallbladder Neoplasms
6
Nasopharyngeal Neoplasms
5
Bile Duct Neoplasms
5
Adenocarcinoma
5
Uterine Cervical Neoplasms
4
Locally Advanced Pancreatic Cancer
4
Endometrial Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Adenocarcinoma
3
Osteosarcoma
3
Lymphoma
3
Interventions
Radiosurgery
2
neratinib
1
lutetium Lu 177 dotatate
1
capivasertib
1
avasopasem manganese
1
Valproic Acid
1
Taxes
1
Sevoflurane
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Propofol
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Gemcitabine
1
Everolimus
1
Etoposide
1
Cystectomy
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
Cisplatin
1
Carboplatin
1
Blood Specimen Collection
1
Biopsy
1
Anesthesia, Inhalation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Disease Progression
×
Gemcitabine
×
Clear all
NCT07049055
2026-02-27
Carolyn-USA
Engeneic Pty Limited
Phase 1/2
Recruiting
144 enrolled